StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Malin Corporation plc
Irish Stock Exchange:MLC.IR
Sector
Location
Market Cap
USD 41.57 M
Share Price
USD 9.49
Avg Daily Volume
387
Change (1 day)
-0.04%
Change (1 year)
51.36%
Change (YTD)
6.60%
Malin Corporation plc Operating Cash Flow for the year ending December 31, 2024: USD -1.35 M
Malin Corporation plc Operating Cash Flow is USD -1.35 M for the year ending December 31, 2024, a -61.89% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Malin Corporation plc Operating Cash Flow for the year ending December 31, 2023 was USD -3.53 M, a -54.15% change year over year.
-
Malin Corporation plc Operating Cash Flow for the year ending December 31, 2022 was USD -7.70 M, a 47.12% change year over year.
-
Malin Corporation plc Operating Cash Flow for the year ending December 31, 2021 was USD -5.24 M, a 42.89% change year over year.
-
Malin Corporation plc Operating Cash Flow for the year ending December 31, 2020 was USD -3.66 M, a -20.35% change year over year.
Competitors
GE HealthCare Technologies Inc.
USD 75.51
GEHC
+0.31
0.41%
Laboratory Corporation of America Holdings
USD 259.07
LH
+1.62
0.63%
Torrent Pharmaceuticals Limited
USD 39.17
TORNTPHARM.NS
+0.42
1.07%
Ascendis Pharma A/S
USD 175.71
ASND
+7.54
4.48%
Regencell Bioscience Holdings Limited
USD 17.40
RGC
-1.91
-9.89%
Laurus Labs Limited
USD 9.28
LAURUSLABS.NS
+0.20
2.20%
Ipca Laboratories Limited
USD 17.00
IPCALAB.NS
-0.09
-0.53%
ADMA Biologics, Inc.
USD 18.34
ADMA
+0.53
2.98%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
USD 2.06
002603.SZ
+0.01
0.46%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.62
600566.SS
+0.02
0.42%
Pfizer Limited
USD 66.21
PFIZER.NS
-2.04
-2.99%
BGI Genomics Co., Ltd.
USD 6.88
300676.SZ
-0.02
-0.27%
Eris Lifesciences Limited
USD 20.22
ERIS.NS
+0.26
1.31%
Liaoning Cheng Da Co., Ltd.
USD 1.57
600739.SS
+0.01
0.45%
Vimian Group AB (publ)
USD 4.42
VIMIAN.ST
-0.03
-0.70%
Hybio Pharmaceutical Co., Ltd.
USD 2.61
300199.SZ
+0.04
1.65%
NovoCure Limited
USD 18.19
NVCR
+0.68
3.88%
Harmony Biosciences Holdings, Inc.
USD 34.29
HRMY
+1.54
4.70%
Zhejiang Jingxin Pharmaceutical Co., Ltd.
USD 2.11
002020.SZ
+0.01
0.24%
Adaptive Biotechnologies Corporation
USD 11.93
ADPT
+0.19
1.62%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
GE HealthCare Technologies Inc.
USD 75.51
GEHC
+0.31
0.41%
Laboratory Corporation of America Holdings
USD 259.07
LH
+1.62
0.63%
Torrent Pharmaceuticals Limited
USD 39.17
TORNTPHARM.NS
+0.42
1.07%
Ascendis Pharma A/S
USD 175.71
ASND
+7.54
4.48%
Regencell Bioscience Holdings Limited
USD 17.40
RGC
-1.91
-9.89%
Laurus Labs Limited
USD 9.28
LAURUSLABS.NS
+0.20
2.20%
Ipca Laboratories Limited
USD 17.00
IPCALAB.NS
-0.09
-0.53%
ADMA Biologics, Inc.
USD 18.34
ADMA
+0.53
2.98%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
USD 2.06
002603.SZ
+0.01
0.46%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.62
600566.SS
+0.02
0.42%
Pfizer Limited
USD 66.21
PFIZER.NS
-2.04
-2.99%
BGI Genomics Co., Ltd.
USD 6.88
300676.SZ
-0.02
-0.27%
Eris Lifesciences Limited
USD 20.22
ERIS.NS
+0.26
1.31%
Liaoning Cheng Da Co., Ltd.
USD 1.57
600739.SS
+0.01
0.45%
Vimian Group AB (publ)
USD 4.42
VIMIAN.ST
-0.03
-0.70%
Hybio Pharmaceutical Co., Ltd.
USD 2.61
300199.SZ
+0.04
1.65%
NovoCure Limited
USD 18.19
NVCR
+0.68
3.88%
Harmony Biosciences Holdings, Inc.
USD 34.29
HRMY
+1.54
4.70%
Zhejiang Jingxin Pharmaceutical Co., Ltd.
USD 2.11
002020.SZ
+0.01
0.24%
Adaptive Biotechnologies Corporation
USD 11.93
ADPT
+0.19
1.62%